Records containing: Pancreatic Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-05-15A Randomized, Controlled Trial of Intraoperative Celiac Plexus Neurolysis for Patients With Operable (Resectable and Unresectable) Pancreatic and Periampullary Cancer
-
CLINICAL_TRIALS study record update · 2025-05-14Safety and Efficacy of Brodalumab in the Treatment of Immune-Related Adverse Events: A Pilot Study
-
CLINICAL_TRIALS study record update · 2025-05-13Circulating Tumor Cell and Tumor Tissue Models for Predicting Effective Pancreatic Cancer Response
-
CLINICAL_TRIALS study record update · 2025-05-08A Phase II Clinical Study to Evaluate the Efficacy and Safety of TQB2916 Injection Combined With Gemcitabine and Albumin-paclitaxel as First-line Treatment for Metastatic Pancreatic Cance
-
CLINICAL_TRIALS study record update · 2025-05-07High-Protein Oral Nutritional Supplementation in Patients Undergoing Pancreaticoduodenectomy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-05-06Tempus Priority Study: An Observational Study of Patients Who Have Received Comprehensive Genomic Profiling
-
CLINICAL_TRIALS study record update · 2025-05-06Evaluation of the Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy
-
CLINICAL_TRIALS study record update · 2025-05-02Deep Learning for Malignant Degeneration Prediction of Pancreatic Cystic Lesions - Beyond High-risk Stigmata
-
CLINICAL_TRIALS study record update · 2025-05-02An Exploratory Study Evaluating the Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer With Biological Correlative Studies
-
CLINICAL_TRIALS study record update · 2025-05-02Molecular Genetics and Epidemiology of Pancreatic Cancer in Ashkenazi Jewish Patients
-
CLINICAL_TRIALS study record update · 2025-05-02Maximal Ablative Irradiation Because of Encasement (MAIBE) for Patients With Potentially Resectable Locally Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2025-05-02A Phase 1b/2a Three-Part Open-Label Multicenter Study to Evaluate the Safety and Efficacy of LY2880070 as Monotherapy and in Combination With Gemcitabine in Patients With Advanced or Metastatic Cancer
-
CLINICAL_TRIALS study record update · 2025-05-02Fatigue, Physical Functioning, and Quality of Life in Patients With Pancreatic and Periampullary Cancers Following Surgery, Chemotherapy, and/or Radiation Therapy
-
CLINICAL_TRIALS study record update · 2025-05-01Efficacy and Safety of Precut Fistulotomy vs Conventional Cannulation Technique as a Primary Approach to Biliary Access According to the Endoscopist Experience Degree in ERCP
-
CLINICAL_TRIALS study record update · 2025-05-01A Phase I/II, Open Label, Multi-center, Non-randomized Dose Escalation and Dose Expansion Study of AMXI-5001 in Patients With Advanced Malignancies
-
CLINICAL_TRIALS study record update · 2025-04-30A Phase Ib/II, Open-label Clinical Study to Evaluate the Safety, Tolerability and Antitumor Activities of IN10018+Standard Chemotherapy and IN10018+Standard Chemotherapy+KN046 in Subjects With Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2025-04-29A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF PONSEGROMAB IN PATIENTS WITH CANCER, CACHEXIA, AND ELEVATED CONCENTRATIONS OF GDF-15, FOLLOWED BY AN OPTIONAL OPEN-LABEL TREATMENT PERIOD (PROACC -1)
-
CLINICAL_TRIALS study record update · 2025-04-27Validation of a miRNA Panel to Optimize Treatment Response in Patients With Metastatic Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2025-04-27VERIFI: A Multicenter, Case-Control Clinical Validation Study of the Multiplex Blood Protein Biomarker Test, PancreaSure, for Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) in High-Risk Patients
-
CLINICAL_TRIALS study record update · 2025-04-25A Phase 1/2 Study to Evaluate the Safety and Efficacy of A2B530, an Autologous Logic-gated Tmod™ Chimeric Antigen Receptor T Cell (CAR T), in Heterozygous HLA-A*02 Adult Subjects With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression
-
CLINICAL_TRIALS study record update · 2025-04-25An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2025-04-24Survival Outcome Analysis on the Strategy Shift Integrating a Multimodal Therapy of Neoadjuvant Chemotherapy and Extended Pancreatectomy in Pancreatic Cancer: A Clinical Study From a Retrospective Cohort in a Single Institute
-
CLINICAL_TRIALS study record update · 2025-04-22A Phase I Clinical Study of Anti-CEA CAR-T Therapy in the Treatment of CEA-positive Advanced Malignant Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-04-22Clinical Application of a Novel 18F Labeled Fibroblast Activation Protein (FAP) Targeted Molecular Probe in Early Tumor Diagnosis
-
CLINICAL_TRIALS study record update · 2025-04-18A Phase 1b Study to Evaluate HMBD-001 With or Without Chemotherapy in Participants With Advanced Solid Tumors Harboring NRG1 Gene Fusions or Selected HER3 Mutations